Table 1 Characteristics of the patients
Characteristic | Neoadjuvant chemotherapy (n = 26) | Primary surgery (n = 26) | P |
|---|---|---|---|
Median age (y, range) | 62 (21 – 88) | 60 (26 – 81) | NS |
Median parity (range) | 1 (0 – 7) | 1 (0 – 4) | NS |
Median BMI * (range) | 24 (19 – 31) | 22 (16 – 30) | 0.048 |
BMI ≥ 30 (%) | 2 (8) | 2 (8) | NS |
Post-menopausal (%) | 21 (81) | 22 (85) | NS |
Cancer history ** (%) | |||
Familial | 6 (23) | 10 (38) | NS |
Personal | 0 | 2 (8) | |
Familial and personal | 2 (8) | 1 (4) | |
None | 18 (69) | 13 (50) | |
Stage (%) | |||
IIIB | 1 (4) | 3 (12) | 0.045 |
IIIC | 20 (77) | 23 (88) | |
IV | 5 (19) | 0 | |
Histology (%) | |||
Serous | 16 (61) | 14 (54) | NS |
Mucinous | 1 (4) | 0 | |
Endometrioid | 6 (23) | 7 (27) | |
Clear cells | 0 | 4 (15) | |
Undifferentiated | 2 (8) | 1 (4) | |
Other | 1 (4) | 0 | |
Grade (%) | |||
1 | 2 (8) | 4 (16) | NS |
2 | 13 (50) | 11 (42) | |
3 | 9 (34) | 11 (42) | |
Unknown | 2 (8) | 0 | |
Emboli (%) | 6 (23) | 7 (27) | NS |
Pleural effusion (%) | 3 (12) | 0 | NS |
Pre-operative CA125 (%) | |||
≤ 500 U/ml | 8 (31) | 16 (61) | 0.026 |
> 500 U/ml | 18 (69) | 10 (39) |